Pancreatic Cancer

T-cell targeting immunotherapy "still a hypothesis"

Published in Cancer Weekly, December 31st, 2002

Internists at Haukeland University Hospital in Norway recently commented on T-cell targeting immunotherapy for pancreatic cancer.

"Until recently," they said, "this therapeutic strategy has been used as a single specific treatment and clinical studies have demonstrated that tumor-specific T-cell responses can be induced in a subset of patients and even in patients with advanced disease. However, it remains to be demonstrated whether these T-cell responses can mediate clinically relevant antitumor reactivity."

"Furthermore, in vitro studies of cancer cell susceptibility to antitumor T-cell reactivity are often limited to cancer cell lines because...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-12-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry